Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Sherbet Eric | Aug 27, 2024 | Sell | 1,300 | $246.33 | $320,000 |
| BOUSBIB ARI | Mar 1, 2024 | Sell | 16,261 | $250.05 | $4.1M |
| BOUSBIB ARI | Mar 1, 2024 | Sell | 15,417 | $251.03 | $3.9M |
| STAUB W RICHARD | Feb 29, 2024 | Sell | 8,970 | $247.33 | $2.2M |
| STAUB W RICHARD | Feb 29, 2024 | Sell | 3,062 | $248.33 | $760,000 |
| STAUB W RICHARD | Feb 29, 2024 | Sell | 2,068 | $249.08 | $520,000 |
| Knightly Kevin C | Feb 28, 2024 | Sell | 6,425 | $249.94 | $1.6M |
| Knightly Kevin C | Feb 28, 2024 | Sell | 2,182 | $250.83 | $550,000 |
| Sherbet Eric | Feb 16, 2024 | Sell | 1,000 | $241.5 | $240,000 |
| Knightly Kevin C | Feb 16, 2024 | Sell | 4,867 | $241.23 | $1.2M |
| Knightly Kevin C | Feb 16, 2024 | Sell | 4,021 | $241.38 | $970,000 |
| Knightly Kevin C | Feb 16, 2024 | Sell | 3,341 | $240.72 | $800,000 |
| Knightly Kevin C | Feb 16, 2024 | Sell | 1,239 | $240.73 | $300,000 |
| Knightly Kevin C | Dec 1, 2023 | Sell | 6,884 | $213.72 | $1.5M |
| Knightly Kevin C | Dec 1, 2023 | Sell | 5,855 | $214.32 | $1.3M |
| Knightly Kevin C | Dec 1, 2023 | Sell | 378 | $215.29 | $81,000 |
| Panagos Constantinos | Sep 19, 2023 | Sell | 19,898 | $208.69 | $4.2M |
| Panagos Constantinos | Sep 19, 2023 | Sell | 7,419 | $208.63 | $1.5M |
| Knightly Kevin C | Jun 5, 2023 | Sell | 5,820 | $201.89 | $1.2M |
| Knightly Kevin C | May 26, 2023 | Sell | 1 | $198.66 | $200 |
| Knightly Kevin C | Feb 16, 2023 | Sell | 2,772 | $225.57 | $630,000 |
| Knightly Kevin C | Feb 16, 2023 | Sell | 1,674 | $225.68 | $380,000 |
| Sherbet Eric | Feb 14, 2023 | Sell | 1,000 | $230 | $230,000 |
What's the latest insider transaction for IQVIA?
The most recent insider transaction for IQVIA was conducted by Sherbet Eric, who sold 1,300 shares on August 27, 2024 at a price of $246.33 per share.
Which insider has sold the most IQV stock over the last two years?
Knightly Kevin C has sold the most IQV stock in the last 2 years, with a total value of $10M.
What is the total value of insider transactions for IQVIA (IQV) in the last 2 years?
The total value of insider transactions for IQVIA in the last 2 years is negative, amounting to -$28M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on IQVIA's market confidence?
Over the last 2 years, insider transactions for IQVIA have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
